← Russell 3000 cross-section

AGL agilon health, inc.

Trailing twelve months to 2026-06-30 · as filed 2026-08-05, not restated
Healthcare

Scale

Market cap
$1.6bn
Revenue TTM
$5.9bn
Net income TTM
$-232m
Free cash flow
$-85m
Composite score
28.0
Sector rank
#1763

Valuation

P / E
EV / EBITDA
EV / sales
0.3
FCF yield
-5.31%
Earnings yield vs 10-yr
-19.24pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
-3.9%
EBITDA margin
-4.8%
ROE
-102.1%
ROIC
-227.9%
Revenue growth
0.3%

Insider activity, last 90 days

Net open-market
$0.00m
Buyers
0
Sellers
0

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

Platform Membership Details MA members decreased 12% from June 30, 2025, which reflects previously disclosed market exits, as well as payor exits in certain markets resulting from a disciplined approach to contracting focused on profitability. Platform Support Costs Our platform support costs, which include regionally-based support personnel and other operating costs to support our geographies, are expected to decrease over time as a percentage of revenue as our physician partners add members and our revenue grows. …agilon health, inc., 10-Q, period ended 2026-06-30, filed 2026-08-05

Read the full passage →